glp-1 agonists oral π¨ A Pill for Obesity? The First (Non-Peptide) Delivers Good Results - Removing the needle: the unmet
Description
Berberine may potentiate glucose-lowering effects of diabetes medications, increasing hypoglycemia risk when combined with insulin, sulfonylureas, or meglitinides
The reconstituted solution is significantly less stable than the lyophilized form
Long-term use has been shown to reduce the risk of major cardiovascular events by 14%, all-cause mortality by 12%, and hospitalizations for heart failure by 11%
Rev Recent Clin Trials 2015;10:6877
